GRP
IONS icon

Global Retirement Partners’s Ionis Pharmaceuticals IONS Stock Holding History

Global Retirement Partners’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181K Buy
+2,282
New +$172K ﹤0.01% 1642
2025
Q4 		$148K Buy
1,876
+1,853
+8,057% +$140K ﹤0.01% 1659
2025
Q3 		$1.5K Buy
23
+7
+44% +$342 ﹤0.01% 3404
2025
Q2 		$632 Buy
+16
New +$524 ﹤0.01% 3544
2024
Q4 		$2.52K Sell
72
-29
-29% -$1.08K ﹤0.01% 2987
2024
Q3 		$4.05K Buy
101
+3
+3% +$140 ﹤0.01% 2663
2024
Q2 		$4.67K Buy
98
+4
+4% +$164 ﹤0.01% 2645
2024
Q1 		$4.08K Buy
94
+3
+3% +$143 ﹤0.01% 2480
2023
Q4 		$4.64K Buy
91
+33
+57% +$1.58K ﹤0.01% 2350
2023
Q3 		$2.53K Hold
58
– – ﹤0.01% 2447
2023
Q2 		$2.38K Hold
58
– – ﹤0.01% 2476
2023
Q1 		$2.01K Buy
58
+7
+14% +$263 ﹤0.01% 2505
2022
Q4 		$1.93K Hold
51
– – ﹤0.01% 2378
2022
Q3 		$2K Sell
51
-20,380
-100% -$859K ﹤0.01% 2253
2022
Q2 		$756K Buy
20,431
+90
+0.4% +$3.39K 0.06% 288
2022
Q1 		$755K Buy
+20,341
New +$666K 0.06% 290
2021
Q4 		– Sell
-5,784
Closed -$194K – 999
2021
Q3 		$194K Buy
5,784
+471
+9% +$17.7K 0.02% 475
2021
Q2 		$212K Buy
5,313
+702
+15% +$27.5K 0.02% 442
2021
Q1 		$207K Buy
+4,611
New +$257K 0.02% 409
2020
Q2 		– Sell
-41
Closed -$2K – 1664
2020
Q1 		$2K Hold
41
– – ﹤0.01% 1413
2019
Q4 		$2K Hold
41
– – ﹤0.01% 1466
2019
Q3 		$2K Sell
41
-252
-86% -$16.4K ﹤0.01% 1443
2019
Q2 		$19K Hold
293
– – ﹤0.01% 915
2019
Q1 		$24K Hold
293
– – 0.01% 758
2018
Q4 		$16K Buy
293
+62
+27% +$3.16K ﹤0.01% 825
2018
Q3 		$12K Buy
231
+27
+13% +$1.27K ﹤0.01% 983
2018
Q2 		$9K Buy
204
+163
+398% +$7.23K ﹤0.01% 1026
2018
Q1 		$2K Buy
+41
New +$2.08K ﹤0.01% 1340

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Global Retirement Partners's IONS Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Ionis Pharmaceuticals (IONS) in Q2 2026: 2,282 shares worth $181K. The stake represents ﹤0.01% of the portfolio and ranks #1642 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in IONS as recently as Q4 2025.

Global Retirement Partners first reported a position in IONS in Q1 2018 and has held it in 28 quarters since. The position peaked at $756K in Q2 2022. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Global Retirement Partners held 2,282 shares of Ionis Pharmaceuticals worth $181K as of Q2 2026.
  • Ionis Pharmaceuticals was a new Global Retirement Partners position in Q2 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #1642 holding.
  • Global Retirement Partners first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 28 quarters since.
  • Global Retirement Partners's Ionis Pharmaceuticals position peaked at $756K in Q2 2022.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.